Jaslok Hospital in Mumbai has banned drugs manufactured by pharma major
Ranbaxy Laboratories. Consultants at the Hospital said an advisory was put up at the receptionist's circular desk four days ago.
The move comes a few weeks after the pharma major was
slapped with a $500-million fine in the US for having sold adulterated drugs.
The notice doesn't give any reason, but merely states that Ranbaxy medicines won't be available at the hospital and doctors should, as far as possible, not prescribe these drugs, reported a leading Mumbai-based daily.
On May 13, Ranbaxy USA pleaded guilty to "felony charges" relating to distribution of adulterated drugs manufactured at two India units and agreed to pay $500 million -
the largest settlement by a generic medicine maker till date.
The generic drugs were manufactured at Ranbaxy's facilities in Paonta Sahib in Himachal Pradesh and Dewas in Madhya Pradesh.
The settlement included $150 million in payments for a criminal fine and forfeiture and $350 million in payments for civil claims.
In association with Mail Today 
Special 
